Hypoglycaemia as cardiovascular risk factor

1. Mokáň M, Galajda P. Hypoglykémia pri vybraných vnútorných chorobách. Quick Print: Martin 2011. ISBN 978–80–970660–6–2.

2. Gerstein HC, Miller ME, Byington RP et al (The Action to Control Cardiovascular Risk in Diabetes Study Group). Effects of Intensive Glucose Lowering in Type 2 Diabetes. N Engl J Med 2008; 358(24): 2545–2559.

3. Patel A, MacMahon S, Chalmers J et al (ADVANCE Collaborative group). Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008; 358(24): 2560–2572.

4. Duckworth W, Abraira C, Moritz T et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360(2): 129–139.

5. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes. (UKPDS 34). Lancet 1998; 352(9131): 854–865.

6. Holman RR, Paul SK, Bethel A et al. 10-Year Follow-Up of Intensive Glucose Control in Type 2 Diabetes. N Eng J Med 2008; 359(15): 1577–1589.

7. Turnbull FM, Abraira C, Andersoon RJ et.al. Intensive glucose control and macrovascular outcomes in type 2 diabetes. Diabetologia 2009; 52(1): 2288–2298.

8. Tkáč I. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials. Diab Res Clin Pract 2009; 86 (Suppl 1): S57-S62.

9. Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ 2011; 343: d4169. Dostupné z DOI: <http://doi: 10.1136/bmj.d4169>.

10. Hemmingsen B, Lund SS, Gluud C et al.: Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ 2011; 343: d6898. Dostupné z DOI: <http://doi: 10.1136/bmj.d6898>.

11. Bonds DE, Miller ME, Bergenstal RM et al. The association between symptomatic severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010; 340: b4909. Dostupné z DOI: <http://doi: 10.1136/bmj.b4909>.

12. Zoungas S, Patel A, Chalmers J et al. (ADVANCE Collaborative Group). Severe hypoglycemia and risks of vascular events and death. N Engl J Med 2010; 363(15): 1410–1418.

13. Goyal A, Mehta S, Diaz R et al. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 2009; 120(24): 2429–2437.

14. Zarich SW. The role of intesive glycemic control in the management of patients who have acute myocardial infarction. Cardiol Clin 2005; 23(2): 109–117.

15. Svensson AM, McGuire DK, Abrahamson P et al. Association between hyper- and hypoglycaemia and 2-year all-caused mortality risk in diabetic patients with acute coronary events. Eur J Heart 2005; 26(13): 1255–1261.

16. Melbin LG, Malmberg K, Waldenstrom A et al. Prognostic implications of hypoglycaemic episode during hospitalisation for myocardial infarction in patiens with type 2 diabetes: a report from DIGAMI 2 trial. Heart 2009; 95(9): 921–927.

17. Whitcomb BW, Pradhan EK, Pittas AG et al. Impact of admission hyperglycemia on hospital mortality in various intensive care unit population. Crit Care Med 2005; 33(12): 2272–2277.

18. Fahy BG, Sheehy AM, Coursin DB. Glucose control in the intensive care unit. Crit Care Med 2009; 37(5): 1969–1976.

19. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345(19): 1359–1367.

20. Finfer S, Chittock DR, Su SY et al (NICE-SUGAR Study Investigators). Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360(13): 1283–1297.

21. Griesdale DEG, de Souza RJ, van Dam RB et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180(8): 821–827.

22. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: A meta-analysis. JAMA 2008; 300(8): 933–944.

23. Ceriello A, Zarich SW, Testa R et al. Lowering glucose to present averse cardiovascular outcomes in critical care setting. J Am Col Cardiol 2009; 53(Suppl 5): S9-S13.

24. Shan L, Hao PP, Chen YG. Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis. J Trauma 2011; 71(5): 1460–1464.

25. Wright RJ, Frier BM. Vascular disease and diabetes: is hypoglycaemia an aggravating factor? Diab Metab Res Rew 2008; 24(5): 353–363.

26. Desouza CV, Bolli GB, Fonseca V. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care 2010; 33(6): 1389–1394.

27. Castaldo E, Sabato D, Lauro D et al. Hypoglycemia assessed by continuous glucose monitoring is associated with preclinical atherosclerosis in individuals with impaired glucose tolerance. PLosOne 2011; 6(12): e28312. Dostupné z DOI: <http://doi: 10.1371/journal.pone.0028312>.

28. Lipska KJ, Kosiborod M. Hypoglycemia and adverse outcomes: marker or mediator? Rev Cardiovasc Med 2011; 12(3): 132–135.

29. Nordin C. The case of hypoglycaemia as a proarrythmic event: basic and clinical evidence. Diabetologia 2010; 53(8): 1552–1561.

30. Galajda P, Mokáň M. Poruchy hemostázy pri diabetes mellitus. P+M: Martin 2001. 255 s.

31. Dantz D, Bewersdorf J, Fruehwald-Schultes B et al. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrin Metab 2002; 37(2): 835–840.

32. Gogitidze JN, Hedrington MS, Briscoe VJ et al. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care 2010; 33(7): 1529–1535.

33. Wright RJ, Newby DE, Stirling D et al. Effects of acute insulin-induced hypoglycemia on indices of inflammation: putative mechanism for aggravating vascular disease in diabetes. Diabetes Care 2010; 33(7): 1591–1597.

34. Kristensen PL, Høi-Hansen T, Olsen NV et al. Erythropoetin during hypoglycaemia in type 1 diabetes: Relation to basal renin-angiotensin system activity and cognitive function. Diab Res Clin Pract 2009; 85(1): 75–84.